COVID-19 in Africa: preexisting immunity and HIV
AIDS
.
2021 Nov 15;35(14):2391-2393.
doi: 10.1097/QAD.0000000000003079.
Authors
Jumari Snyman
1
2
,
Eduard J Sanders
3
4
,
Thumbi Ndung'u
1
2
5
6
Affiliations
1
Africa Health Research Institute.
2
HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
3
Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya.
4
Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
5
Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, USA.
6
Division of Infection and Immunity, University College London, London, UK.
PMID:
34723854
PMCID:
PMC8567318
DOI:
10.1097/QAD.0000000000003079
No abstract available
Publication types
Editorial
Comment
MeSH terms
Africa / epidemiology
COVID-19*
HIV Infections*
Humans
SARS-CoV-2
Grants and funding
D71 TW009572/TW/FIC NIH HHS/United States